Arvee Laboratories India Q4 FY26 Results: PAT Rs 3.20 Cr

Arvee Laboratories India Q4 FY26 results were declared on May 19, 2026. Arvee Laboratories India reported PAT of Rs 3.20 crore up 28.0% YoY from Rs 2.50 crore in Q4 FY25, on revenue of Rs 52 crore up 18.0% YoY. Arvee Laboratories India is a Pharmaceutical APIs company listed on Indian stock exchanges. This article covers the complete Arvee Laboratories India Q4 FY26 financial highlights, key performance factors, and FY27 outlook.

Click Here – Get Free Investment Predictions

Arvee Laboratories India Q4 FY26 Financial Highlights

Note: Q4 FY26 PAT Rs 3.2 crore (+28% YoY) on revenue Rs 52 crore (+18% YoY). Active pharmaceutical ingredients manufacturer.

Arvee Laboratories India Q4 FY26 Performance Analysis

the firm results reflect the January to March 2026 quarter performance. Arvee Laboratories India operates in the Pharmaceutical APIs sector, supported by India’s GDP growth and domestic demand environment. The Q4 FY26 results demonstrate continued operational execution.

Screen the best stocks on the Univest Screener.

Key Business Factors for the company

Revenue and Operations

it covers the seasonally important January to March 2026 quarter. India’s macro environment with GDP above 6.5% and strong domestic consumption provided a constructive backdrop for the Pharmaceutical APIs sector.

Profitability Trends

the business PAT of Rs 3.20 crore up 28.0% YoY from Rs 2.50 crore in Q4 FY25. Margin recovery and operating leverage will be key watchpoints entering FY27.

FY27 Outlook

Following the firm results, management commentary on FY27 guidance, capex plans, and demand outlook will drive investor sentiment. The Pharmaceutical APIs sector continues to benefit from India’s structural growth story.

India Macro Environment Q4 FY26

The January to March 2026 quarter concluded India’s fiscal year 2025-26. India’s GDP growth remained above 6.5%, supported by strong government capital expenditure, rural consumption recovery, and resilient urban demand. The Reserve Bank of India maintained an accommodative monetary stance which provided liquidity support across sectors. For companies across manufacturing, services, and infrastructure, this macro backdrop translated into sustained demand conditions during the quarter. Investors evaluating the quarterly performance should contextualise individual results within this broader economic environment.

Sectoral Trends and Competitive Position

Companies reporting Q4 FY26 results operate within a dynamic competitive landscape shaped by domestic policy priorities, global supply chain realignments, and evolving consumer preferences. Government initiatives including Production Linked Incentive schemes, infrastructure pipeline expansion, and MSME support measures created tailwinds for multiple sectors during FY26. The earnings season provides an opportunity to assess how individual companies have navigated input cost pressures, workforce efficiency, and capital allocation decisions across this period.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on the company

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.